PMID- 3970731 OWN - NLM STAT- MEDLINE DCOM- 19850321 LR - 20190718 IS - 0004-3591 (Print) IS - 0004-3591 (Linking) VI - 28 IP - 2 DP - 1985 Feb TI - The binding of antihistone antibodies to Crithidia luciliae kinetoplasts is growth cycle-dependent. PG - 163-8 AB - The Crithidia luciliae immunofluorescence (CLIF) assay is widely used to test for native DNA (nDNA) antibodies in the diagnosis and management of systemic lupus erythematosus. However, sera from patients with drug-induced lupus erythematosus or rheumatoid arthritis, which should not contain nDNA antibodies, occasionally react with the CL kinetoplast. We examined 36 sera from patients with systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, and drug-induced lupus erythematosus, who had positive CLIF tests. All 36 sera were also antinuclear antibody-positive with homogeneous and/or peripheral staining patterns on mouse kidney substrates. After hydrochloric acid extraction of the CL smears to remove histone and other nuclear protein antigens, 14 of the 36 sera no longer produced a positive result on the CLIF test. Ten of these 14 sera again gave a positive CLIF result after the hydrochloric acid-extracted Crithidia substrate had been reconstituted with purified histone. These studies demonstrated that kinetoplast binding was due to antihistone antibodies in at least 10 of 36 initially CLIF-positive sera. Antihistone antibodies were then purified with a histone-affinity column, and these purified antibodies were reactive with CL kinetoplasts. Thus, the CLIF test is not specific for nDNA antibodies. Additional studies using CL from different days of culture indicated that histone antigen expression in the CL kinetoplast was a function of the life cycle of this organism and is most readily detected 2 days after initiation of culture. FAU - Deng, J S AU - Deng JS FAU - Sontheimer, R D AU - Sontheimer RD FAU - Lipscomb, M F AU - Lipscomb MF FAU - Gilliam, J N AU - Gilliam JN LA - eng GR - AI17363/AI/NIAID NIH HHS/United States GR - AM00730/AM/NIADDK NIH HHS/United States GR - AM19101/AM/NIADDK NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Arthritis Rheum JT - Arthritis and rheumatism JID - 0370605 RN - 0 (Autoantibodies) RN - 0 (Histones) SB - IM MH - Animals MH - Arthritis, Rheumatoid/immunology MH - Autoantibodies/*immunology MH - *Binding Sites, Antibody MH - Crithidia/growth & development/*immunology MH - Histones/*immunology MH - Humans MH - Kidney/immunology MH - Kinetics MH - Lupus Erythematosus, Systemic/immunology MH - Mice/immunology EDAT- 1985/02/01 00:00 MHDA- 1985/02/01 00:01 CRDT- 1985/02/01 00:00 PHST- 1985/02/01 00:00 [pubmed] PHST- 1985/02/01 00:01 [medline] PHST- 1985/02/01 00:00 [entrez] AID - 10.1002/art.1780280210 [doi] PST - ppublish SO - Arthritis Rheum. 1985 Feb;28(2):163-8. doi: 10.1002/art.1780280210.